Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011.

[1]  M. Unemo,et al.  Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. , 2012, Future microbiology.

[2]  R. Kirkcaldy,et al.  Effectiveness of gentamicin for gonorrhoea treatment: systematic review and meta-analysis , 2012, Postgraduate Medical Journal.

[3]  M. Unemo,et al.  The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health , 2012, Sexually Transmitted Infections.

[4]  M. Unemo,et al.  In Vitro Activity of the New Fluoroketolide Solithromycin (CEM-101) against a Large Collection of Clinical Neisseria gonorrhoeae Isolates and International Reference Strains, Including Those with High-Level Antimicrobial Resistance: Potential Treatment Option for Gonorrhea? , 2012, Antimicrobial Agents and Chemotherapy.

[5]  C. Lowndes,et al.  Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales. , 2011, The Journal of antimicrobial chemotherapy.

[6]  C Bignell,et al.  UK national guideline for the management of gonorrhoea in adults, 2011 , 2011, International journal of STD & AIDS.

[7]  T. Nichols,et al.  Estimating the prevalence of gonococcal resistance to antimicrobials in England and Wales , 2011, Sexually Transmitted Infections.

[8]  P. Penney,et al.  Cefixime-resistant Neisseria gonorrhoeae in the UK: a time to reflect on practice and recommendations , 2011, International journal of STD & AIDS.

[9]  K. Sankar,et al.  Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[10]  D. Livermore,et al.  Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink? , 2010, The Journal of antimicrobial chemotherapy.

[11]  D. Lewis.  The Gonococcus fights back: is this time a knock out? , 2010, Sexually Transmitted Infections.

[12]  M. Yasuda,et al.  Rapid Detection of the Mosaic Structure of the Neisseria gonorrhoeae penA Gene, Which Is Associated with Decreased Susceptibilities to Oral Cephalosporins , 2008, Journal of Clinical Microbiology.

[13]  Roberta J. Lindberg,et al.  Neisseria gonorrhoeae Isolates with Reduced Susceptibility to Cefixime and Ceftriaxone: Association with Genetic Polymorphisms in penA, mtrR, porB1b, and ponA , 2007, Antimicrobial Agents and Chemotherapy.

[14]  Kevin A Fenton,et al.  Identification of individuals with gonorrhoea within sexual networks: a population-based study , 2006, The Lancet.

[15]  K. Fenton,et al.  Increasing rates of sexually transmitted diseases in homosexual men in Western europe and the United States: why? , 2005, Infectious disease clinics of North America.

[16]  B. Vuylsteke,et al.  Current status of syndromic management of sexually transmitted infections in developing countries , 2004, Sexually Transmitted Infections.

[17]  M. Yasuda,et al.  Remarkable Increase in Central Japan in 2001-2002 of Neisseria gonorrhoeae Isolates with Decreased Susceptibility to Penicillin, Tetracycline, Oral Cephalosporins, and Fluoroquinolones , 2004, Antimicrobial Agents and Chemotherapy.

[18]  J. Andrews.  BSAC standardized disc susceptibility testing method (version 8). , 2004, The Journal of antimicrobial chemotherapy.

[19]  D. Schlossberg,et al.  Multicenter Trial of Single‐Dose Azithromycin vs. Ceftriaxone in the Treatment of Uncomplicated Gonorrhea , 1994, Sexually transmitted diseases.

[20]  J. Martin,et al.  Comparative study of gonococcal susceptibility to penicillin in the United States, 1955-1969. , 1970, The Journal of infectious diseases.

[21]  W. Maury,et al.  Ebolavirus: a brief review of novel therapeutic targets. , 2012, Future microbiology.